Heritage Cannabis is looking to deliver improved absorption of CB with ArthroCB. The Toronto-based company’s softgel capsules includes 25 mg of CBD and 6 mg of beta carophyllene to facilitate faster absorption.
“We are excited to launch our clinically tested ArthroCBD softgel capsules for those seeking daily relief from physical strain. Physicians, pharmacists, and other health care practitioners all want the same thing – to provide the best treatment for patients with the least side effects. ArthroCBD now provides that option with a highly effective, hemp-based CBD product,” said Umar Syed, president of medical products at Heritage. “Carefully formulated CBD with pharmaceutical technology, high-quality tested ingredients, and clinical testing to prove product performance is a logical step in the evolution of hemp-based CBD products. Our focus is to finally provide patients and the medical and healthcare communities with products based on credible data that they can trust to work well and safely.”
Heritage said that its team has more than 30 years of experience in pharmaceuticals and the OTC consumer market. Its products use VESIsorb, a technology designed to help boost the performance of pharmaceutical and wellness products. The company said ArthroCBD is the first of more than seven new hemp-based CBD product offerings it plans to launch.